![](https://european-biotechnology.com/wp-content/uploads/2024/04/sam-agus-266x300.jpg)
Hansa Medical: Taking charge of medical affairs
Hansa Medical, Lund-based developer of novel immunomodulatory enzymes, has recruited Sam Agus as Chief Medical Officer. Agus joins from H. Lundbeck AS, where he was Chief Specialist, Medical Affairs Neurology.
Agus is a board-certified neurologist; his therapy area expertise includes neurology, psychiatry, gastroenterology, womens health and rare diseases. He has previously held leading positions at several pharmaceutical companies, including Shire, Solvay Pharmaceuticals and Abbott Laboratories.